tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Similar Stocks

Compare
2,282 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ACADIA Pharmaceuticals
$19.95
$3.38B
26.27
-19.72%
5 Buy
5 Hold
0 Sell
Moderate Buy
Neurocrine
$120.69
$11.36B
34.72
-7.62%
17 Buy
5 Hold
0 Sell
Strong Buy
Prothena
$15.56
$820.58M
-42.48%
5 Buy
2 Hold
0 Sell
Moderate Buy
Intra-Cellular Therapies
$128.60
$13.67B
75.49%
5 Buy
9 Hold
0 Sell
Moderate Buy
SAGE Therapeutics
$7.31
$439.59M
-67.07%
2 Buy
13 Hold
0 Sell
Hold
Axsome Therapeutics
$137.75
$6.30B
67.76%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ACAD
ACADIA Pharmaceuticals
19.95
-4.90
-19.72%
NBIX
Neurocrine
120.69
-12.68
-9.51%
PRTA
Prothena
15.56
-11.39
-42.26%
ITCI
Intra-Cellular Therapies
128.60
56.67
78.78%
SAGE
SAGE Therapeutics
7.31
-14.94
-67.15%
AXSM
Axsome Therapeutics
137.75
57.28
71.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis